Business Wire

Cognito Therapeutics Raises $73M Series B to Advance Neurotechnology Platform for Alzheimer’s Disease

Top-tier investor syndicate led by FoundersX Ventures, with participation from all existing investors and new investors Alzheimer’s Drug Discovery Foundation (ADDF), Starbloom Capital, IAG Capital and ...
Business Wire

Cognito Therapeutics and Providence Health Plan Launch Phase 3 Study to Evaluate Disease-Modifying Therapeutic in Mild Cognitive Impairment

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cognito Therapeutics and Providence Health Plan today announced a collaboration to conduct a Phase 3 study of Cognito’s breakthrough, non-invasive disease-modifying ...
Forbes

$105 Million Brings Cognito, And Neurotech, to a Pivotal Stage

Forbes contributors publish independent expert analyses and insights. I’m an analyst covering neurotech's impact on business and society. This voice experience is generated by AI. Learn more. This ...
techtimes

Cognito’s Alzheimer’s Treatment Headset Is Cleared for Large-scale Trials

Clinical-stage company Cognito Therapeutics reportedly secured a large-scale trial to treat Alzheimer's disease using a device instead of medicine. Bloomberg reports that the aforementioned ...